Proteinuria in Nephrotic Range
2 clinical trials · Condition
◉ Watch Proteinuria in Nephrotic Range
| Record | Firm | Date |
|---|---|---|
| Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria (NCT07224776) | Brigham and Women's Hospital | 2026-07-10 |
| Registry of IgA Nephropathy in Chinese Children (NCT03015974) | Peking University First Hospital | 2016-01-01 |
Track Proteinuria in Nephrotic Range automatically
Every clearance here is in the API, with alerts when new ones post.